Phenazopyridine Plus

Generic name: phenazopyridine hydrochloride, butabarbital, and hyoscyamine hydrobromide
Dosage form: tablet, coated
Drug class:Urinary antispasmodics

Medically reviewed by Drugs.com. Last updated on Dec 22, 2021.

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

Rx Only

Phenazopyridine Plus Description

Each Phenazopyridine Plus Tablet contains:

Inactive Ingredients: Microcrystalline Cellulose, Croscarmellose Sodium, Pregelatinized Starch, Povidone K-30, Maize Starch, Magnesium Stearate, Hypromellose, Polyethylene Glycol 400, 1FD&C Yellow No. 6, FD&C Blue No. 1, FD&C Red No. 40 and Titanium Dioxide.

1

This product contains FD&C Yellow No. 6 as a color additive.

Phenazopyridine Plus - Clinical Pharmacology

Phenazopyridine Plus relieves lower urinary symptoms of pain, frequency, urgency, burning, and dysuria, arising from inflammation of the urothelium, the mucosal lining of the lower urinary tract.

Lower urinary tract pain can cause reflex spasm of the detrusor. Pain and spasm are often aggravated by apprehension to promote a pain-spasm-apprehension cycle. Each of the three pharmacologic components of Phenazopyridine Plus acts against a phase of this cycle.

Phenazopyridine hydrochloride, excreted in the urine, is a topical analgesic for the relief of pain and discomfort.

Hyoscyamine hydrobromide, a parasympatholytic, acts to relieve detrusor musc...